Lyme disease is the most common arthropod-borne infection in the United States. Over 100,000 cases have been reported to date. The disease is a multisystem disorder with dermatologic, neurologic and rheumatologic manifestations. The spirochete, Borrelia burgdorferi, is the causative agent. Central to the disease process, in the absence of a demonstrated toxin, is the interaction between the microorganism and host cells. In order to examine whether cells undergo detectable, cytopathic changes in response to spirochetes, we have undertaken to assess possible interactions between B. burgdorferi and both primary or cultured human cells in vitro. Cytoadhesive receptors expressed on cell surfaces are essential for cell-cell interaction and adhesion to the extracellular matrix. Many microorganisms have evolved the ability to use these surface receptors, called integrins, to bind and then to invade host cells. This ability often becomes an important virulence determinant. A broadly applicable method was developed in which scanning electron microscopy is used to sensitively and specifically assess this important binding potential under carefully controlled conditions. The rapid assay which uses commercially available, genetically engineered cytoadhesive molecules and site specific competitive inhibitors in a convenient filter/cell culture insert format may be used to yield either qualitative and/or quantitative data. Furthermore, the specimens appear suitable for high resolution SEM examination as well following the initial assay. The efficient use of the fibronectin, but not the vitronectin or laminin, cellular binding receptor by Borrelia burgdorferi was demonstrated using the SEM assay method. Gentle disruption and washing of bound spirochetes with N-lauroylsarcosine followed by detergent elution and polyacrylamide gel electrophoresis of bound polypeptides revealed a unique, limited subset of binding components. Borrelial major outer surface protein A (OspA) was most prominent among them.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000488-12
Application #
6098946
Study Section
Special Emphasis Panel (RMLM)
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Carabeo, Reynaldo A; Grieshaber, Scott S; Fischer, Elizabeth et al. (2002) Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun 70:3793-803
Hoe, Nancy P; Ireland, Robin M; DeLeo, Frank R et al. (2002) Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc Natl Acad Sci U S A 99:7646-51
Baron, Gerald S; Wehrly, Kathy; Dorward, David W et al. (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 21:1031-40
Fields, K A; Fischer, E; Hackstadt, T (2002) Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA. Infect Immun 70:3816-23
Mukhopadhyay, M; Shtrom, S; Rodriguez-Esteban, C et al. (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 1:423-34
Park, H S; Wolfgang, M; van Putten, J P et al. (2001) Structural alterations in a type IV pilus subunit protein result in concurrent defects in multicellular behaviour and adherence to host tissue. Mol Microbiol 42:293-307
Zieler, H; Garon, C F; Fischer, E R et al. (2000) A tubular network associated with the brush-border surface of the Aedes aegypti midgut: implications for pathogen transmission by mosquitoes. J Exp Biol 203:1599-611
Carroll, J A; Garon, C F; Schwan, T G (1999) Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun 67:3181-7
Garon, C F; Oury, J H; Duran, C M (1999) Virus-like particles in the mitral and tricuspid valves explanted from a patient treated with Fenfluramine-Phentermine. J Heart Valve Dis 8:232